Author: Robert Miller Guthrie
Publisher: Jones & Bartlett Publishers
ISBN: 1449618065
Category : Medical
Languages : en
Pages : 146
Book Description
An essential resource for all cardiologists, internists, and medical residents, Pharmacological Management of Hypertension and Dyslipidemia assists clinicians in the treatment of hypertension and high cholesterol, the two most easily diagnosed and treatable risk factors for cardiovascular disease. This concise yet complete handbook includes the scientific background for each drug class presented, and includes a review of the science supporting the utilization of the agents in particular patient situations. The medications and their doses and dosage forms are presented in easy to use tables, so that the practitioners can quickly access the information to make their treatment decisions, whether they are in the hospital or in an outpatient setting.
Hypertension and Dyslipidemia Management Essentials
Author: Robert Miller Guthrie
Publisher: Jones & Bartlett Publishers
ISBN: 1449618065
Category : Medical
Languages : en
Pages : 146
Book Description
An essential resource for all cardiologists, internists, and medical residents, Pharmacological Management of Hypertension and Dyslipidemia assists clinicians in the treatment of hypertension and high cholesterol, the two most easily diagnosed and treatable risk factors for cardiovascular disease. This concise yet complete handbook includes the scientific background for each drug class presented, and includes a review of the science supporting the utilization of the agents in particular patient situations. The medications and their doses and dosage forms are presented in easy to use tables, so that the practitioners can quickly access the information to make their treatment decisions, whether they are in the hospital or in an outpatient setting.
Publisher: Jones & Bartlett Publishers
ISBN: 1449618065
Category : Medical
Languages : en
Pages : 146
Book Description
An essential resource for all cardiologists, internists, and medical residents, Pharmacological Management of Hypertension and Dyslipidemia assists clinicians in the treatment of hypertension and high cholesterol, the two most easily diagnosed and treatable risk factors for cardiovascular disease. This concise yet complete handbook includes the scientific background for each drug class presented, and includes a review of the science supporting the utilization of the agents in particular patient situations. The medications and their doses and dosage forms are presented in easy to use tables, so that the practitioners can quickly access the information to make their treatment decisions, whether they are in the hospital or in an outpatient setting.
Disease Control Priorities, Third Edition (Volume 5)
Author: Dorairaj Prabhakaran
Publisher: World Bank Publications
ISBN: 1464805202
Category : Medical
Languages : en
Pages : 948
Book Description
Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.
Publisher: World Bank Publications
ISBN: 1464805202
Category : Medical
Languages : en
Pages : 948
Book Description
Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.
Coronary Primary Prevention Trial
Author:
Publisher:
ISBN:
Category : Coronary heart disease
Languages : en
Pages : 2
Book Description
Publisher:
ISBN:
Category : Coronary heart disease
Languages : en
Pages : 2
Book Description
Statin-Associated Muscle Symptoms
Author: Paul D. Thompson
Publisher: Springer Nature
ISBN: 3030333043
Category : Medical
Languages : en
Pages : 191
Book Description
This book provides an overview of statin-associated muscle symptoms (SAMS) from clinical presentation to treatment and possible metabolic causes. It examines the risk factors, presentations, diagnosis and differential diagnosis, clinical management, and financial costs of SAMS. The book also highlights patients’ perspectives on SAMS such as the psychosocial, emotional, and societal factors influencing their perceptions and experiences. Finally, the book presents the results of observational and clinical trials on the prevalence of SAMS, clinical trials for treatments, and potential future research approaches for improving the understanding and treatment of SAMS. A key addition to the Contemporary Cardiology series, Statin-Associated Muscle Symptoms is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in cardiology, endocrinology, pharmacotherapy, primary care, and health promotion and disease prevention.
Publisher: Springer Nature
ISBN: 3030333043
Category : Medical
Languages : en
Pages : 191
Book Description
This book provides an overview of statin-associated muscle symptoms (SAMS) from clinical presentation to treatment and possible metabolic causes. It examines the risk factors, presentations, diagnosis and differential diagnosis, clinical management, and financial costs of SAMS. The book also highlights patients’ perspectives on SAMS such as the psychosocial, emotional, and societal factors influencing their perceptions and experiences. Finally, the book presents the results of observational and clinical trials on the prevalence of SAMS, clinical trials for treatments, and potential future research approaches for improving the understanding and treatment of SAMS. A key addition to the Contemporary Cardiology series, Statin-Associated Muscle Symptoms is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in cardiology, endocrinology, pharmacotherapy, primary care, and health promotion and disease prevention.
Diabetes and Hypertension
Author: Samy I. McFarlane
Publisher: Springer Science & Business Media
ISBN: 1603273573
Category : Medical
Languages : en
Pages : 196
Book Description
Diabetes and hypertension have evolved as two of the modern day epidemics affecting millions of people around the world. These two common co-morbidities lead to substantial increase in cardiovascular disease, the major cause of morbidity and mortality of adults around the world. In Diabetes and Hypertension: Evaluation and Management, a panel of renowned experts address a range of critical topics -- from basic concepts in evaluation and management of diabetes and hypertension, such as dietary interventions, to evaluation and management of secondary hypertension in clinical practice. Other chapters focus on high cardiovascular risk populations such as those with coronary heart disease, chronic kidney disease and minority patients. In addition, evolving concepts and new developments in the field are presented in other chapters, such as prevention of type 2 diabetes and the epidemic of sleep apnea and its implication for diabetes and hypertension evaluation and management. An important title covering two of the most troubling disorders of our time, Diabetes and Hypertension: Evaluation and Management will provide the busy practitioner with cutting edge knowledge in the field as well as practical information that can translate into better care provided to the high-risk population of diabetics and hypertensive patients.
Publisher: Springer Science & Business Media
ISBN: 1603273573
Category : Medical
Languages : en
Pages : 196
Book Description
Diabetes and hypertension have evolved as two of the modern day epidemics affecting millions of people around the world. These two common co-morbidities lead to substantial increase in cardiovascular disease, the major cause of morbidity and mortality of adults around the world. In Diabetes and Hypertension: Evaluation and Management, a panel of renowned experts address a range of critical topics -- from basic concepts in evaluation and management of diabetes and hypertension, such as dietary interventions, to evaluation and management of secondary hypertension in clinical practice. Other chapters focus on high cardiovascular risk populations such as those with coronary heart disease, chronic kidney disease and minority patients. In addition, evolving concepts and new developments in the field are presented in other chapters, such as prevention of type 2 diabetes and the epidemic of sleep apnea and its implication for diabetes and hypertension evaluation and management. An important title covering two of the most troubling disorders of our time, Diabetes and Hypertension: Evaluation and Management will provide the busy practitioner with cutting edge knowledge in the field as well as practical information that can translate into better care provided to the high-risk population of diabetics and hypertensive patients.
Management of Dyslipidemia
Author: Wilbert S. Aronow
Publisher: BoD – Books on Demand
ISBN: 1839685077
Category : Medical
Languages : en
Pages : 176
Book Description
Dyslipidemia is a major risk factor for cardiovascular events, cardiovascular mortality, and all-cause mortality. The earlier in life dyslipidemia is treated, the better the prognosis. The current book is an excellent one on dyslipidemia written by experts on this topic. This book includes 12 chapters including 5 on lipids, 4 on hypercholesterolemia in children, and 3 on the treatment of dyslipidemia. This book should be read by all health care professionals taking care of patients, including pediatricians since atherosclerotic cardiovascular disease begins in childhood.
Publisher: BoD – Books on Demand
ISBN: 1839685077
Category : Medical
Languages : en
Pages : 176
Book Description
Dyslipidemia is a major risk factor for cardiovascular events, cardiovascular mortality, and all-cause mortality. The earlier in life dyslipidemia is treated, the better the prognosis. The current book is an excellent one on dyslipidemia written by experts on this topic. This book includes 12 chapters including 5 on lipids, 4 on hypercholesterolemia in children, and 3 on the treatment of dyslipidemia. This book should be read by all health care professionals taking care of patients, including pediatricians since atherosclerotic cardiovascular disease begins in childhood.
From Hypertension to Heart Failure
Author: Michael Böhm
Publisher: Springer Science & Business Media
ISBN: 3642603009
Category : Medical
Languages : en
Pages : 299
Book Description
Arterial hypertension, coronary heart disease and heart fail ure are the commonest cardiovascular conditions to present in clinical practice. Over the past few years it has become in creasingly clear that they are closely and causally interrelated and that their relationship can have a significant bearing on prognosis. Epidemiological studies have shown that arterial hypertension is one of the most important risk factors for de veloping heart failure. Only one in four patients with hyper tension is adequately managed, and in 50% of cases, the hypertension has not been recognised or treated. Patients with pre-existing hypertension who go on to suffer an acute myocardial infarction have usually not previously had typi cal angina symptoms, the infarct territory is larger, life threatening arrhythmias are commoner and hence in-hospi tal mortality and long-term prognosis are markedly worse. The presence of raised blood pressure in the post-infarct phase doubles the risk of manifest heart failure. The close relationship between hypertension, coronary heart disease and heart failure makes the choice of therapeu tic strategy particularly important. Agents and classes of agents that have prognostic value in all three conditions should be considered first, as synergy might result in addi tional benefits. In such patients, this sort of therapeutic deci sion-making might have further advantages. The use of these agents may prevent complications which are not yet clinically obvious (such as heart failure).
Publisher: Springer Science & Business Media
ISBN: 3642603009
Category : Medical
Languages : en
Pages : 299
Book Description
Arterial hypertension, coronary heart disease and heart fail ure are the commonest cardiovascular conditions to present in clinical practice. Over the past few years it has become in creasingly clear that they are closely and causally interrelated and that their relationship can have a significant bearing on prognosis. Epidemiological studies have shown that arterial hypertension is one of the most important risk factors for de veloping heart failure. Only one in four patients with hyper tension is adequately managed, and in 50% of cases, the hypertension has not been recognised or treated. Patients with pre-existing hypertension who go on to suffer an acute myocardial infarction have usually not previously had typi cal angina symptoms, the infarct territory is larger, life threatening arrhythmias are commoner and hence in-hospi tal mortality and long-term prognosis are markedly worse. The presence of raised blood pressure in the post-infarct phase doubles the risk of manifest heart failure. The close relationship between hypertension, coronary heart disease and heart failure makes the choice of therapeu tic strategy particularly important. Agents and classes of agents that have prognostic value in all three conditions should be considered first, as synergy might result in addi tional benefits. In such patients, this sort of therapeutic deci sion-making might have further advantages. The use of these agents may prevent complications which are not yet clinically obvious (such as heart failure).
Carbon Dioxide Angiography
Author: Kyung Cho
Publisher: CRC Press
ISBN: 1420016261
Category : Medical
Languages : en
Pages : 310
Book Description
With an abundance of illustrations and tables to highlight critical information, this source provides a practical approach to the use of CO2 as a contrast agent for diagnostic angiography, vascular intervention, and other interventional procedures in both adults and pediatrics. Clearly laying-out key points in the science, technique, and clinical a
Publisher: CRC Press
ISBN: 1420016261
Category : Medical
Languages : en
Pages : 310
Book Description
With an abundance of illustrations and tables to highlight critical information, this source provides a practical approach to the use of CO2 as a contrast agent for diagnostic angiography, vascular intervention, and other interventional procedures in both adults and pediatrics. Clearly laying-out key points in the science, technique, and clinical a
Hypertension and Brain Damage
Author: Antonio Coca
Publisher: Springer Nature
ISBN: 3031649281
Category :
Languages : en
Pages : 310
Book Description
Publisher: Springer Nature
ISBN: 3031649281
Category :
Languages : en
Pages : 310
Book Description
Lipid Management
Author: Hussein Yassine
Publisher: Springer
ISBN: 3319111612
Category : Medical
Languages : en
Pages : 268
Book Description
This timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.
Publisher: Springer
ISBN: 3319111612
Category : Medical
Languages : en
Pages : 268
Book Description
This timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.